Celcuity (CELC) Stock Forecast & Price Target

Compare

457 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CELC Analyst Ratings

Strong Buy

9 Buy

1 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Celcuity

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CELC Stock 12 Month Forecast

Average Price Target

$101.88

▼(-3.20% Downside)

Based on 10 Wall Street analysts offering 12 month price targets for Celcuity in the last 3 months. The average price target is $101.88 with a high forecast of $126.00 and a low forecast of $70.00. The average price target represents a -3.20% change from the last price of $105.25.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","127":"$127","37.75":"$37.8","67.5":"$67.5","97.25":"$97.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":126,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$126.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":101.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$101.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$70.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,37.75,67.5,97.25,127],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.48,100.59692307692308,102.71384615384616,104.83076923076923,106.94769230769231,109.0646153846154,111.18153846153847,113.29846153846154,115.41538461538462,117.5323076923077,119.64923076923077,121.76615384615386,123.88307692307693,{"y":126,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.48,98.74153846153847,99.00307692307693,99.26461538461538,99.52615384615385,99.78769230769231,100.04923076923077,100.31076923076922,100.57230769230769,100.83384615384615,101.09538461538462,101.35692307692307,101.61846153846153,{"y":101.88,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.48,96.28923076923077,94.09846153846154,91.90769230769232,89.71692307692308,87.52615384615385,85.33538461538461,83.14461538461538,80.95384615384616,78.76307692307692,76.57230769230769,74.38153846153847,72.19076923076923,{"y":70,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.63,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.95,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.43,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.29,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.62,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.22,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.16,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.48,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$126.00

Average Price Target$101.88

Lowest Price Target$70.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Chase Knickerbocker

Craig-Hallum

―

Buy

―

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC) and Joint (NASDAQ: JYNT)

Eva Fortea Verdejo

Wells Fargo

$126

Buy

19.71%

Upside

Initiated

12/12/25

Celcuity (CELC) Receives a Buy from Wells Fargo

Swayampakula Ramakanth

H.C. Wainwright

$77→$94

Hold

-10.69%

Downside

Downgraded

11/17/25

Celcuity downgraded to Neutral from Buy at H.C. WainwrightCelcuity downgraded to Neutral from Buy at H.C. Wainwright

Unknown Analyst

Wolfe Research

Not Ranked

Wolfe Research

$110

Buy

4.51%

Upside

Initiated

11/17/25

Celcuity initiated with an Outperform at Wolfe ResearchCelcuity initiated with an Outperform at Wolfe Research

Oliver McCammon

LifeSci Capital

$65→$95

Buy

-9.74%

Downside

Reiterated

11/14/25

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC) and Pelthos Therapeutics (NYSE MKT: PTHS)

Stephen Willey

Stifel Nicolaus

$68→$115

Buy

9.26%

Upside

Reiterated

11/13/25

Stifel Nicolaus Sticks to Its Buy Rating for Celcuity (CELC)increasing our target price to $115 based on updated VIKTORIA-1 estimates and remain Buy-rated.

Gil Blum

Needham

$95

Buy

-9.74%

Downside

Reiterated

11/13/25

Celcuity's Strategic Advances and Robust Financials Justify Buy Rating

Tara Bancroft

TD Cowen

―

Buy

―

Reiterated

11/12/25

Celcuity's Giredestrant: A Promising Standard for 2L Breast Cancer Treatment

Andrew Berens

Leerink Partners

$60→$70

Buy

-33.49%

Downside

Reiterated

10/21/25

Leerink Partners Keeps Their Buy Rating on Celcuity (CELC)

Bradley Canino

Guggenheim

$110

Buy

4.51%

Upside

Reiterated

09/25/25

We think CELC remains a Buy into the 2026 2L PIK3CA wild-type launch.

Maury Raycroft

Jefferies

$54→$79

Buy

-24.94%

Downside

Reiterated

08/15/25

Jefferies Sticks to Their Buy Rating for Celcuity (CELC)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Chase Knickerbocker

Craig-Hallum

―

Buy

―

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC) and Joint (NASDAQ: JYNT)

Eva Fortea Verdejo

Wells Fargo

$126

Buy

19.71%

Upside

Initiated

12/12/25

Celcuity (CELC) Receives a Buy from Wells Fargo

Swayampakula Ramakanth

H.C. Wainwright

$77→$94

Hold

-10.69%

Downside

Downgraded

11/17/25

Celcuity downgraded to Neutral from Buy at H.C. WainwrightCelcuity downgraded to Neutral from Buy at H.C. Wainwright

Unknown Analyst

Wolfe Research

Not Ranked

Wolfe Research

$110

Buy

4.51%

Upside

Initiated

11/17/25

Celcuity initiated with an Outperform at Wolfe ResearchCelcuity initiated with an Outperform at Wolfe Research

Oliver McCammon

LifeSci Capital

$65→$95

Buy

-9.74%

Downside

Reiterated

11/14/25

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC) and Pelthos Therapeutics (NYSE MKT: PTHS)

Stephen Willey

Stifel Nicolaus

$68→$115

Buy

9.26%

Upside

Reiterated

11/13/25

Stifel Nicolaus Sticks to Its Buy Rating for Celcuity (CELC)increasing our target price to $115 based on updated VIKTORIA-1 estimates and remain Buy-rated.

Gil Blum

Needham

$95

Buy

-9.74%

Downside

Reiterated

11/13/25

Celcuity's Strategic Advances and Robust Financials Justify Buy Rating

Tara Bancroft

TD Cowen

―

Buy

―

Reiterated

11/12/25

Celcuity's Giredestrant: A Promising Standard for 2L Breast Cancer Treatment

Andrew Berens

Leerink Partners

$60→$70

Buy

-33.49%

Downside

Reiterated

10/21/25

Leerink Partners Keeps Their Buy Rating on Celcuity (CELC)

Bradley Canino

Guggenheim

$110

Buy

4.51%

Upside

Reiterated

09/25/25

We think CELC remains a Buy into the 2026 2L PIK3CA wild-type launch.

Maury Raycroft

Jefferies

$54→$79

Buy

-24.94%

Downside

Reiterated

08/15/25

Jefferies Sticks to Their Buy Rating for Celcuity (CELC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Celcuity

1 Month

xxx

Success Rate

6/10 ratings generated profit

Average Return

+31.65%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +31.65% per trade.

3 Months

xxx

Success Rate

9/12 ratings generated profit

Average Return

+97.10%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +97.10% per trade.

1 Year

Chase KnickerbockerCraig-Hallum

Success Rate

11/12 ratings generated profit

Average Return

+394.45%

reiterated a buy rating 2 days ago

Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +394.45% per trade.

2 Years

xxx

Success Rate

12/12 ratings generated profit

Average Return

+469.96%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +469.96% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CELC Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CELC has received 17 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CELC average Analyst price target in the past 3 months is 101.88.

Each month's total comprises the sum of three months' worth of ratings.

CELC Financial Forecast

CELC Earnings Forecast

Next quarter’s earnings estimate for CELC is -$1.04 with a range of -$1.24 to -$0.83. The previous quarter’s EPS was -$0.92. CELC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year CELC has Performed in-line its overall industry.

No data currently available

CELC Sales Forecast

Next quarter’s sales forecast for CELC is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CELC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year CELC has Performed in-line its overall industry.

CELC Stock Forecast FAQ

What is CELC’s average 12-month price target, according to analysts?

Based on analyst ratings, Celcuity’s 12-month average price target is 101.88.

What is CELC’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CELC, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CELC a Buy, Sell or Hold?

Celcuity has a consensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.

What is Celcuity’s price target?

The average price target for Celcuity is 101.88. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $126.00 ,the lowest forecast is $70.00. The average price target represents -3.20% Decrease from the current price of $105.25.

What do analysts say about Celcuity?

Celcuity’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of CELC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Celcuity (CELC) Stock Forecast & Price Target

CELC Analyst Ratings

CELC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Celcuity

CELC Analyst Recommendation Trends

CELC Financial Forecast

CELC Earnings Forecast

CELC Sales Forecast

CELC Stock Forecast FAQ

Detailed List of Analyst Forecasts